nodes	percent_of_prediction	percent_of_DWPC	metapath
Ofloxacin—TOP2A—Epirubicin—pancreatic cancer	0.124	0.173	CbGbCtD
Ofloxacin—ABCC1—Epirubicin—pancreatic cancer	0.0688	0.0959	CbGbCtD
Ofloxacin—ABCC1—Irinotecan—pancreatic cancer	0.0669	0.0933	CbGbCtD
Ofloxacin—TOP2A—Doxorubicin—pancreatic cancer	0.066	0.0919	CbGbCtD
Ofloxacin—ABCC2—Tamoxifen—pancreatic cancer	0.0645	0.0899	CbGbCtD
Ofloxacin—ABCC2—Irinotecan—pancreatic cancer	0.0495	0.069	CbGbCtD
Ofloxacin—ABCC1—Docetaxel—pancreatic cancer	0.0491	0.0684	CbGbCtD
Ofloxacin—ABCC1—Doxorubicin—pancreatic cancer	0.0366	0.051	CbGbCtD
Ofloxacin—ABCC2—Docetaxel—pancreatic cancer	0.0363	0.0506	CbGbCtD
Ofloxacin—ABCC2—Sunitinib—pancreatic cancer	0.0361	0.0504	CbGbCtD
Ofloxacin—CYP1A2—Dacarbazine—pancreatic cancer	0.0302	0.0421	CbGbCtD
Ofloxacin—ABCC2—Doxorubicin—pancreatic cancer	0.0271	0.0377	CbGbCtD
Ofloxacin—CYP1A2—Tamoxifen—pancreatic cancer	0.0241	0.0335	CbGbCtD
Ofloxacin—CYP1A2—Erlotinib—pancreatic cancer	0.0205	0.0285	CbGbCtD
Ofloxacin—CYP1A2—Fluorouracil—pancreatic cancer	0.0177	0.0247	CbGbCtD
Ofloxacin—ABCC2—bile duct—pancreatic cancer	0.00538	0.482	CbGeAlD
Ofloxacin—ABCC2—bile—pancreatic cancer	0.00414	0.37	CbGeAlD
Ofloxacin—TOP2A—Topotecan—Irinotecan—pancreatic cancer	0.00115	0.24	CbGdCrCtD
Ofloxacin—TOP2A—Paclitaxel—Docetaxel—pancreatic cancer	0.000804	0.168	CbGdCrCtD
Ofloxacin—TOP2A—Gefitinib—Erlotinib—pancreatic cancer	0.000771	0.162	CbGdCrCtD
Ofloxacin—SLC22A4—digestive system—pancreatic cancer	0.000529	0.0474	CbGeAlD
Ofloxacin—ABCC2—digestive system—pancreatic cancer	0.000452	0.0405	CbGeAlD
Ofloxacin—SLC22A5—digestive system—pancreatic cancer	0.00035	0.0313	CbGeAlD
Ofloxacin—CYP1A2—digestive system—pancreatic cancer	0.000317	0.0284	CbGeAlD
Ofloxacin—TOP2A—Cytarabine—Gemcitabine—pancreatic cancer	0.00029	0.0608	CbGdCrCtD
Ofloxacin—TOP2A—Doxorubicin—Epirubicin—pancreatic cancer	0.000269	0.0564	CbGdCrCtD
Ofloxacin—TOP2A—Daunorubicin—Epirubicin—pancreatic cancer	0.000269	0.0564	CbGdCrCtD
Ofloxacin—TOP2A—Idarubicin—Epirubicin—pancreatic cancer	0.000269	0.0564	CbGdCrCtD
Ofloxacin—TOP2A—Idarubicin—Doxorubicin—pancreatic cancer	0.000249	0.0522	CbGdCrCtD
Ofloxacin—TOP2A—Daunorubicin—Doxorubicin—pancreatic cancer	0.000249	0.0522	CbGdCrCtD
Ofloxacin—TOP2A—Epirubicin—Doxorubicin—pancreatic cancer	0.000249	0.0522	CbGdCrCtD
Ofloxacin—TOP2A—Azacitidine—Gemcitabine—pancreatic cancer	0.000208	0.0436	CbGdCrCtD
Ofloxacin—ABCC1—Cobalamin (Cbl, vitamin B12) transport and metabolism—PRSS1—pancreatic cancer	0.000132	0.0675	CbGpPWpGaD
Ofloxacin—Weight decreased—Doxorubicin—pancreatic cancer	7.36e-05	0.000278	CcSEcCtD
Ofloxacin—Sinusitis—Epirubicin—pancreatic cancer	7.35e-05	0.000278	CcSEcCtD
Ofloxacin—Hyperglycaemia—Doxorubicin—pancreatic cancer	7.34e-05	0.000277	CcSEcCtD
Ofloxacin—Diarrhoea—Irinotecan—pancreatic cancer	7.33e-05	0.000277	CcSEcCtD
Ofloxacin—Agranulocytosis—Epirubicin—pancreatic cancer	7.31e-05	0.000277	CcSEcCtD
Ofloxacin—Pneumonia—Doxorubicin—pancreatic cancer	7.29e-05	0.000276	CcSEcCtD
Ofloxacin—Shock—Docetaxel—pancreatic cancer	7.29e-05	0.000276	CcSEcCtD
Ofloxacin—Nervous system disorder—Docetaxel—pancreatic cancer	7.27e-05	0.000275	CcSEcCtD
Ofloxacin—Pruritus—Fluorouracil—pancreatic cancer	7.26e-05	0.000275	CcSEcCtD
Ofloxacin—Thrombocytopenia—Docetaxel—pancreatic cancer	7.25e-05	0.000274	CcSEcCtD
Ofloxacin—Drowsiness—Doxorubicin—pancreatic cancer	7.25e-05	0.000274	CcSEcCtD
Ofloxacin—Infestation—Doxorubicin—pancreatic cancer	7.25e-05	0.000274	CcSEcCtD
Ofloxacin—Infestation NOS—Doxorubicin—pancreatic cancer	7.25e-05	0.000274	CcSEcCtD
Ofloxacin—Tachycardia—Docetaxel—pancreatic cancer	7.23e-05	0.000273	CcSEcCtD
Ofloxacin—Skin disorder—Docetaxel—pancreatic cancer	7.2e-05	0.000272	CcSEcCtD
Ofloxacin—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	7.19e-05	0.000272	CcSEcCtD
Ofloxacin—Bradycardia—Epirubicin—pancreatic cancer	7.16e-05	0.000271	CcSEcCtD
Ofloxacin—Diarrhoea—Gemcitabine—pancreatic cancer	7.14e-05	0.00027	CcSEcCtD
Ofloxacin—Renal failure—Doxorubicin—pancreatic cancer	7.13e-05	0.00027	CcSEcCtD
Ofloxacin—Neuropathy peripheral—Doxorubicin—pancreatic cancer	7.11e-05	0.000269	CcSEcCtD
Ofloxacin—Dizziness—Irinotecan—pancreatic cancer	7.09e-05	0.000268	CcSEcCtD
Ofloxacin—Haemoglobin—Epirubicin—pancreatic cancer	7.07e-05	0.000267	CcSEcCtD
Ofloxacin—Jaundice—Doxorubicin—pancreatic cancer	7.07e-05	0.000267	CcSEcCtD
Ofloxacin—Stomatitis—Doxorubicin—pancreatic cancer	7.07e-05	0.000267	CcSEcCtD
Ofloxacin—Anorexia—Docetaxel—pancreatic cancer	7.06e-05	0.000267	CcSEcCtD
Ofloxacin—Rhinitis—Epirubicin—pancreatic cancer	7.05e-05	0.000267	CcSEcCtD
Ofloxacin—Conjunctivitis—Doxorubicin—pancreatic cancer	7.05e-05	0.000267	CcSEcCtD
Ofloxacin—Haemorrhage—Epirubicin—pancreatic cancer	7.03e-05	0.000266	CcSEcCtD
Ofloxacin—Hepatitis—Epirubicin—pancreatic cancer	7.03e-05	0.000266	CcSEcCtD
Ofloxacin—Diarrhoea—Fluorouracil—pancreatic cancer	7.02e-05	0.000266	CcSEcCtD
Ofloxacin—Hypoaesthesia—Epirubicin—pancreatic cancer	7e-05	0.000265	CcSEcCtD
Ofloxacin—Pharyngitis—Epirubicin—pancreatic cancer	6.98e-05	0.000264	CcSEcCtD
Ofloxacin—Urinary tract disorder—Epirubicin—pancreatic cancer	6.95e-05	0.000263	CcSEcCtD
Ofloxacin—Oedema peripheral—Epirubicin—pancreatic cancer	6.93e-05	0.000262	CcSEcCtD
Ofloxacin—Hypotension—Docetaxel—pancreatic cancer	6.92e-05	0.000262	CcSEcCtD
Ofloxacin—Haematuria—Doxorubicin—pancreatic cancer	6.91e-05	0.000261	CcSEcCtD
Ofloxacin—Connective tissue disorder—Epirubicin—pancreatic cancer	6.91e-05	0.000261	CcSEcCtD
Ofloxacin—Urethral disorder—Epirubicin—pancreatic cancer	6.9e-05	0.000261	CcSEcCtD
Ofloxacin—Hepatobiliary disease—Doxorubicin—pancreatic cancer	6.86e-05	0.000259	CcSEcCtD
Ofloxacin—Epistaxis—Doxorubicin—pancreatic cancer	6.84e-05	0.000259	CcSEcCtD
Ofloxacin—Vomiting—Irinotecan—pancreatic cancer	6.81e-05	0.000258	CcSEcCtD
Ofloxacin—Sinusitis—Doxorubicin—pancreatic cancer	6.8e-05	0.000257	CcSEcCtD
Ofloxacin—Dizziness—Fluorouracil—pancreatic cancer	6.79e-05	0.000257	CcSEcCtD
Ofloxacin—Visual impairment—Epirubicin—pancreatic cancer	6.78e-05	0.000256	CcSEcCtD
Ofloxacin—Agranulocytosis—Doxorubicin—pancreatic cancer	6.77e-05	0.000256	CcSEcCtD
Ofloxacin—Rash—Irinotecan—pancreatic cancer	6.76e-05	0.000256	CcSEcCtD
Ofloxacin—Dermatitis—Irinotecan—pancreatic cancer	6.75e-05	0.000255	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	6.75e-05	0.000255	CcSEcCtD
Ofloxacin—Headache—Irinotecan—pancreatic cancer	6.71e-05	0.000254	CcSEcCtD
Ofloxacin—Insomnia—Docetaxel—pancreatic cancer	6.7e-05	0.000253	CcSEcCtD
Ofloxacin—Paraesthesia—Docetaxel—pancreatic cancer	6.65e-05	0.000252	CcSEcCtD
Ofloxacin—Erythema multiforme—Epirubicin—pancreatic cancer	6.65e-05	0.000252	CcSEcCtD
Ofloxacin—Vomiting—Gemcitabine—pancreatic cancer	6.64e-05	0.000251	CcSEcCtD
Ofloxacin—Bradycardia—Doxorubicin—pancreatic cancer	6.63e-05	0.000251	CcSEcCtD
Ofloxacin—Dyspnoea—Docetaxel—pancreatic cancer	6.61e-05	0.00025	CcSEcCtD
Ofloxacin—Somnolence—Docetaxel—pancreatic cancer	6.59e-05	0.000249	CcSEcCtD
Ofloxacin—Rash—Gemcitabine—pancreatic cancer	6.58e-05	0.000249	CcSEcCtD
Ofloxacin—Dermatitis—Gemcitabine—pancreatic cancer	6.58e-05	0.000249	CcSEcCtD
Ofloxacin—Eye disorder—Epirubicin—pancreatic cancer	6.57e-05	0.000249	CcSEcCtD
Ofloxacin—Tinnitus—Epirubicin—pancreatic cancer	6.56e-05	0.000248	CcSEcCtD
Ofloxacin—Haemoglobin—Doxorubicin—pancreatic cancer	6.54e-05	0.000247	CcSEcCtD
Ofloxacin—Headache—Gemcitabine—pancreatic cancer	6.54e-05	0.000247	CcSEcCtD
Ofloxacin—Flushing—Epirubicin—pancreatic cancer	6.53e-05	0.000247	CcSEcCtD
Ofloxacin—Cardiac disorder—Epirubicin—pancreatic cancer	6.53e-05	0.000247	CcSEcCtD
Ofloxacin—Vomiting—Fluorouracil—pancreatic cancer	6.53e-05	0.000247	CcSEcCtD
Ofloxacin—Rhinitis—Doxorubicin—pancreatic cancer	6.53e-05	0.000247	CcSEcCtD
Ofloxacin—Dyspepsia—Docetaxel—pancreatic cancer	6.52e-05	0.000247	CcSEcCtD
Ofloxacin—Haemorrhage—Doxorubicin—pancreatic cancer	6.51e-05	0.000246	CcSEcCtD
Ofloxacin—Hepatitis—Doxorubicin—pancreatic cancer	6.51e-05	0.000246	CcSEcCtD
Ofloxacin—Hypoaesthesia—Doxorubicin—pancreatic cancer	6.48e-05	0.000245	CcSEcCtD
Ofloxacin—Rash—Fluorouracil—pancreatic cancer	6.47e-05	0.000245	CcSEcCtD
Ofloxacin—Dermatitis—Fluorouracil—pancreatic cancer	6.47e-05	0.000245	CcSEcCtD
Ofloxacin—Pharyngitis—Doxorubicin—pancreatic cancer	6.46e-05	0.000244	CcSEcCtD
Ofloxacin—Decreased appetite—Docetaxel—pancreatic cancer	6.44e-05	0.000244	CcSEcCtD
Ofloxacin—Headache—Fluorouracil—pancreatic cancer	6.43e-05	0.000243	CcSEcCtD
Ofloxacin—Urinary tract disorder—Doxorubicin—pancreatic cancer	6.43e-05	0.000243	CcSEcCtD
Ofloxacin—Oedema peripheral—Doxorubicin—pancreatic cancer	6.41e-05	0.000242	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Docetaxel—pancreatic cancer	6.4e-05	0.000242	CcSEcCtD
Ofloxacin—Connective tissue disorder—Doxorubicin—pancreatic cancer	6.4e-05	0.000242	CcSEcCtD
Ofloxacin—Fatigue—Docetaxel—pancreatic cancer	6.39e-05	0.000242	CcSEcCtD
Ofloxacin—Angiopathy—Epirubicin—pancreatic cancer	6.38e-05	0.000241	CcSEcCtD
Ofloxacin—Urethral disorder—Doxorubicin—pancreatic cancer	6.38e-05	0.000241	CcSEcCtD
Ofloxacin—Nausea—Irinotecan—pancreatic cancer	6.37e-05	0.000241	CcSEcCtD
Ofloxacin—Immune system disorder—Epirubicin—pancreatic cancer	6.35e-05	0.00024	CcSEcCtD
Ofloxacin—Mediastinal disorder—Epirubicin—pancreatic cancer	6.34e-05	0.00024	CcSEcCtD
Ofloxacin—Pain—Docetaxel—pancreatic cancer	6.34e-05	0.00024	CcSEcCtD
Ofloxacin—Constipation—Docetaxel—pancreatic cancer	6.34e-05	0.00024	CcSEcCtD
Ofloxacin—Chills—Epirubicin—pancreatic cancer	6.31e-05	0.000239	CcSEcCtD
Ofloxacin—Arrhythmia—Epirubicin—pancreatic cancer	6.28e-05	0.000238	CcSEcCtD
Ofloxacin—Visual impairment—Doxorubicin—pancreatic cancer	6.27e-05	0.000237	CcSEcCtD
Ofloxacin—Alopecia—Epirubicin—pancreatic cancer	6.22e-05	0.000235	CcSEcCtD
Ofloxacin—Nausea—Gemcitabine—pancreatic cancer	6.2e-05	0.000235	CcSEcCtD
Ofloxacin—Mental disorder—Epirubicin—pancreatic cancer	6.16e-05	0.000233	CcSEcCtD
Ofloxacin—Erythema multiforme—Doxorubicin—pancreatic cancer	6.15e-05	0.000233	CcSEcCtD
Ofloxacin—Malnutrition—Epirubicin—pancreatic cancer	6.12e-05	0.000232	CcSEcCtD
Ofloxacin—Erythema—Epirubicin—pancreatic cancer	6.12e-05	0.000232	CcSEcCtD
Ofloxacin—Feeling abnormal—Docetaxel—pancreatic cancer	6.11e-05	0.000231	CcSEcCtD
Ofloxacin—Nausea—Fluorouracil—pancreatic cancer	6.1e-05	0.000231	CcSEcCtD
Ofloxacin—Eye disorder—Doxorubicin—pancreatic cancer	6.08e-05	0.00023	CcSEcCtD
Ofloxacin—Tinnitus—Doxorubicin—pancreatic cancer	6.07e-05	0.00023	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Docetaxel—pancreatic cancer	6.06e-05	0.000229	CcSEcCtD
Ofloxacin—Flushing—Doxorubicin—pancreatic cancer	6.04e-05	0.000228	CcSEcCtD
Ofloxacin—Cardiac disorder—Doxorubicin—pancreatic cancer	6.04e-05	0.000228	CcSEcCtD
Ofloxacin—Flatulence—Epirubicin—pancreatic cancer	6.03e-05	0.000228	CcSEcCtD
Ofloxacin—Tension—Epirubicin—pancreatic cancer	6.01e-05	0.000227	CcSEcCtD
Ofloxacin—Dysgeusia—Epirubicin—pancreatic cancer	6e-05	0.000227	CcSEcCtD
Ofloxacin—Nervousness—Epirubicin—pancreatic cancer	5.95e-05	0.000225	CcSEcCtD
Ofloxacin—ABCC2—NRF2 pathway—FGF13—pancreatic cancer	5.94e-05	0.0303	CbGpPWpGaD
Ofloxacin—Back pain—Epirubicin—pancreatic cancer	5.92e-05	0.000224	CcSEcCtD
Ofloxacin—Angiopathy—Doxorubicin—pancreatic cancer	5.91e-05	0.000223	CcSEcCtD
Ofloxacin—Muscle spasms—Epirubicin—pancreatic cancer	5.89e-05	0.000223	CcSEcCtD
Ofloxacin—Immune system disorder—Doxorubicin—pancreatic cancer	5.88e-05	0.000222	CcSEcCtD
Ofloxacin—Mediastinal disorder—Doxorubicin—pancreatic cancer	5.87e-05	0.000222	CcSEcCtD
Ofloxacin—Body temperature increased—Docetaxel—pancreatic cancer	5.86e-05	0.000222	CcSEcCtD
Ofloxacin—Abdominal pain—Docetaxel—pancreatic cancer	5.86e-05	0.000222	CcSEcCtD
Ofloxacin—Chills—Doxorubicin—pancreatic cancer	5.84e-05	0.000221	CcSEcCtD
Ofloxacin—Arrhythmia—Doxorubicin—pancreatic cancer	5.81e-05	0.00022	CcSEcCtD
Ofloxacin—Vision blurred—Epirubicin—pancreatic cancer	5.77e-05	0.000218	CcSEcCtD
Ofloxacin—Alopecia—Doxorubicin—pancreatic cancer	5.75e-05	0.000218	CcSEcCtD
Ofloxacin—Mental disorder—Doxorubicin—pancreatic cancer	5.7e-05	0.000216	CcSEcCtD
Ofloxacin—Ill-defined disorder—Epirubicin—pancreatic cancer	5.68e-05	0.000215	CcSEcCtD
Ofloxacin—Malnutrition—Doxorubicin—pancreatic cancer	5.67e-05	0.000214	CcSEcCtD
Ofloxacin—Erythema—Doxorubicin—pancreatic cancer	5.67e-05	0.000214	CcSEcCtD
Ofloxacin—Anaemia—Epirubicin—pancreatic cancer	5.66e-05	0.000214	CcSEcCtD
Ofloxacin—Agitation—Epirubicin—pancreatic cancer	5.63e-05	0.000213	CcSEcCtD
Ofloxacin—Flatulence—Doxorubicin—pancreatic cancer	5.58e-05	0.000211	CcSEcCtD
Ofloxacin—Tension—Doxorubicin—pancreatic cancer	5.56e-05	0.00021	CcSEcCtD
Ofloxacin—Dysgeusia—Doxorubicin—pancreatic cancer	5.55e-05	0.00021	CcSEcCtD
Ofloxacin—Malaise—Epirubicin—pancreatic cancer	5.52e-05	0.000209	CcSEcCtD
Ofloxacin—Nervousness—Doxorubicin—pancreatic cancer	5.5e-05	0.000208	CcSEcCtD
Ofloxacin—Vertigo—Epirubicin—pancreatic cancer	5.5e-05	0.000208	CcSEcCtD
Ofloxacin—Syncope—Epirubicin—pancreatic cancer	5.49e-05	0.000208	CcSEcCtD
Ofloxacin—Leukopenia—Epirubicin—pancreatic cancer	5.48e-05	0.000207	CcSEcCtD
Ofloxacin—Back pain—Doxorubicin—pancreatic cancer	5.48e-05	0.000207	CcSEcCtD
Ofloxacin—Hypersensitivity—Docetaxel—pancreatic cancer	5.46e-05	0.000206	CcSEcCtD
Ofloxacin—Muscle spasms—Doxorubicin—pancreatic cancer	5.45e-05	0.000206	CcSEcCtD
Ofloxacin—Palpitations—Epirubicin—pancreatic cancer	5.41e-05	0.000205	CcSEcCtD
Ofloxacin—Loss of consciousness—Epirubicin—pancreatic cancer	5.38e-05	0.000204	CcSEcCtD
Ofloxacin—Cough—Epirubicin—pancreatic cancer	5.34e-05	0.000202	CcSEcCtD
Ofloxacin—Vision blurred—Doxorubicin—pancreatic cancer	5.34e-05	0.000202	CcSEcCtD
Ofloxacin—Asthenia—Docetaxel—pancreatic cancer	5.32e-05	0.000201	CcSEcCtD
Ofloxacin—Hypertension—Epirubicin—pancreatic cancer	5.29e-05	0.0002	CcSEcCtD
Ofloxacin—Ill-defined disorder—Doxorubicin—pancreatic cancer	5.26e-05	0.000199	CcSEcCtD
Ofloxacin—Pruritus—Docetaxel—pancreatic cancer	5.24e-05	0.000198	CcSEcCtD
Ofloxacin—Anaemia—Doxorubicin—pancreatic cancer	5.24e-05	0.000198	CcSEcCtD
Ofloxacin—Myalgia—Epirubicin—pancreatic cancer	5.21e-05	0.000197	CcSEcCtD
Ofloxacin—Arthralgia—Epirubicin—pancreatic cancer	5.21e-05	0.000197	CcSEcCtD
Ofloxacin—Chest pain—Epirubicin—pancreatic cancer	5.21e-05	0.000197	CcSEcCtD
Ofloxacin—Agitation—Doxorubicin—pancreatic cancer	5.21e-05	0.000197	CcSEcCtD
Ofloxacin—Anxiety—Epirubicin—pancreatic cancer	5.2e-05	0.000196	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	5.18e-05	0.000196	CcSEcCtD
Ofloxacin—Discomfort—Epirubicin—pancreatic cancer	5.15e-05	0.000195	CcSEcCtD
Ofloxacin—Malaise—Doxorubicin—pancreatic cancer	5.11e-05	0.000193	CcSEcCtD
Ofloxacin—Dry mouth—Epirubicin—pancreatic cancer	5.1e-05	0.000193	CcSEcCtD
Ofloxacin—Vertigo—Doxorubicin—pancreatic cancer	5.09e-05	0.000193	CcSEcCtD
Ofloxacin—Syncope—Doxorubicin—pancreatic cancer	5.08e-05	0.000192	CcSEcCtD
Ofloxacin—Leukopenia—Doxorubicin—pancreatic cancer	5.07e-05	0.000192	CcSEcCtD
Ofloxacin—Diarrhoea—Docetaxel—pancreatic cancer	5.07e-05	0.000192	CcSEcCtD
Ofloxacin—Confusional state—Epirubicin—pancreatic cancer	5.04e-05	0.000191	CcSEcCtD
Ofloxacin—Palpitations—Doxorubicin—pancreatic cancer	5.01e-05	0.000189	CcSEcCtD
Ofloxacin—Anaphylactic shock—Epirubicin—pancreatic cancer	5e-05	0.000189	CcSEcCtD
Ofloxacin—Oedema—Epirubicin—pancreatic cancer	5e-05	0.000189	CcSEcCtD
Ofloxacin—Loss of consciousness—Doxorubicin—pancreatic cancer	4.98e-05	0.000188	CcSEcCtD
Ofloxacin—Infection—Epirubicin—pancreatic cancer	4.96e-05	0.000188	CcSEcCtD
Ofloxacin—Cough—Doxorubicin—pancreatic cancer	4.94e-05	0.000187	CcSEcCtD
Ofloxacin—Shock—Epirubicin—pancreatic cancer	4.92e-05	0.000186	CcSEcCtD
Ofloxacin—Nervous system disorder—Epirubicin—pancreatic cancer	4.9e-05	0.000185	CcSEcCtD
Ofloxacin—Dizziness—Docetaxel—pancreatic cancer	4.9e-05	0.000185	CcSEcCtD
Ofloxacin—Thrombocytopenia—Epirubicin—pancreatic cancer	4.89e-05	0.000185	CcSEcCtD
Ofloxacin—Hypertension—Doxorubicin—pancreatic cancer	4.89e-05	0.000185	CcSEcCtD
Ofloxacin—Tachycardia—Epirubicin—pancreatic cancer	4.88e-05	0.000184	CcSEcCtD
Ofloxacin—Skin disorder—Epirubicin—pancreatic cancer	4.85e-05	0.000184	CcSEcCtD
Ofloxacin—Hyperhidrosis—Epirubicin—pancreatic cancer	4.83e-05	0.000183	CcSEcCtD
Ofloxacin—Chest pain—Doxorubicin—pancreatic cancer	4.82e-05	0.000182	CcSEcCtD
Ofloxacin—Arthralgia—Doxorubicin—pancreatic cancer	4.82e-05	0.000182	CcSEcCtD
Ofloxacin—Myalgia—Doxorubicin—pancreatic cancer	4.82e-05	0.000182	CcSEcCtD
Ofloxacin—Anxiety—Doxorubicin—pancreatic cancer	4.81e-05	0.000182	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	4.79e-05	0.000181	CcSEcCtD
Ofloxacin—Discomfort—Doxorubicin—pancreatic cancer	4.77e-05	0.00018	CcSEcCtD
Ofloxacin—Anorexia—Epirubicin—pancreatic cancer	4.76e-05	0.00018	CcSEcCtD
Ofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	4.72e-05	0.0241	CbGpPWpGaD
Ofloxacin—Dry mouth—Doxorubicin—pancreatic cancer	4.72e-05	0.000178	CcSEcCtD
Ofloxacin—Vomiting—Docetaxel—pancreatic cancer	4.71e-05	0.000178	CcSEcCtD
Ofloxacin—Rash—Docetaxel—pancreatic cancer	4.67e-05	0.000177	CcSEcCtD
Ofloxacin—Hypotension—Epirubicin—pancreatic cancer	4.67e-05	0.000177	CcSEcCtD
Ofloxacin—Dermatitis—Docetaxel—pancreatic cancer	4.67e-05	0.000177	CcSEcCtD
Ofloxacin—Confusional state—Doxorubicin—pancreatic cancer	4.66e-05	0.000176	CcSEcCtD
Ofloxacin—Headache—Docetaxel—pancreatic cancer	4.64e-05	0.000176	CcSEcCtD
Ofloxacin—Anaphylactic shock—Doxorubicin—pancreatic cancer	4.62e-05	0.000175	CcSEcCtD
Ofloxacin—Oedema—Doxorubicin—pancreatic cancer	4.62e-05	0.000175	CcSEcCtD
Ofloxacin—Infection—Doxorubicin—pancreatic cancer	4.59e-05	0.000174	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	4.55e-05	0.000172	CcSEcCtD
Ofloxacin—Shock—Doxorubicin—pancreatic cancer	4.55e-05	0.000172	CcSEcCtD
Ofloxacin—Nervous system disorder—Doxorubicin—pancreatic cancer	4.53e-05	0.000172	CcSEcCtD
Ofloxacin—Thrombocytopenia—Doxorubicin—pancreatic cancer	4.53e-05	0.000171	CcSEcCtD
Ofloxacin—Insomnia—Epirubicin—pancreatic cancer	4.52e-05	0.000171	CcSEcCtD
Ofloxacin—Tachycardia—Doxorubicin—pancreatic cancer	4.51e-05	0.000171	CcSEcCtD
Ofloxacin—Skin disorder—Doxorubicin—pancreatic cancer	4.49e-05	0.00017	CcSEcCtD
Ofloxacin—Paraesthesia—Epirubicin—pancreatic cancer	4.49e-05	0.00017	CcSEcCtD
Ofloxacin—Hyperhidrosis—Doxorubicin—pancreatic cancer	4.47e-05	0.000169	CcSEcCtD
Ofloxacin—Dyspnoea—Epirubicin—pancreatic cancer	4.46e-05	0.000169	CcSEcCtD
Ofloxacin—Somnolence—Epirubicin—pancreatic cancer	4.44e-05	0.000168	CcSEcCtD
Ofloxacin—Anorexia—Doxorubicin—pancreatic cancer	4.41e-05	0.000167	CcSEcCtD
Ofloxacin—Nausea—Docetaxel—pancreatic cancer	4.4e-05	0.000166	CcSEcCtD
Ofloxacin—Dyspepsia—Epirubicin—pancreatic cancer	4.4e-05	0.000166	CcSEcCtD
Ofloxacin—Decreased appetite—Epirubicin—pancreatic cancer	4.34e-05	0.000164	CcSEcCtD
Ofloxacin—Hypotension—Doxorubicin—pancreatic cancer	4.32e-05	0.000163	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Epirubicin—pancreatic cancer	4.31e-05	0.000163	CcSEcCtD
Ofloxacin—Fatigue—Epirubicin—pancreatic cancer	4.31e-05	0.000163	CcSEcCtD
Ofloxacin—Pain—Epirubicin—pancreatic cancer	4.27e-05	0.000162	CcSEcCtD
Ofloxacin—Constipation—Epirubicin—pancreatic cancer	4.27e-05	0.000162	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	4.21e-05	0.000159	CcSEcCtD
Ofloxacin—Insomnia—Doxorubicin—pancreatic cancer	4.18e-05	0.000158	CcSEcCtD
Ofloxacin—Paraesthesia—Doxorubicin—pancreatic cancer	4.15e-05	0.000157	CcSEcCtD
Ofloxacin—Dyspnoea—Doxorubicin—pancreatic cancer	4.12e-05	0.000156	CcSEcCtD
Ofloxacin—Feeling abnormal—Epirubicin—pancreatic cancer	4.12e-05	0.000156	CcSEcCtD
Ofloxacin—Somnolence—Doxorubicin—pancreatic cancer	4.11e-05	0.000155	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Epirubicin—pancreatic cancer	4.09e-05	0.000155	CcSEcCtD
Ofloxacin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PRSS1—pancreatic cancer	4.08e-05	0.0208	CbGpPWpGaD
Ofloxacin—Dyspepsia—Doxorubicin—pancreatic cancer	4.07e-05	0.000154	CcSEcCtD
Ofloxacin—Decreased appetite—Doxorubicin—pancreatic cancer	4.02e-05	0.000152	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	3.99e-05	0.000151	CcSEcCtD
Ofloxacin—Fatigue—Doxorubicin—pancreatic cancer	3.99e-05	0.000151	CcSEcCtD
Ofloxacin—Urticaria—Epirubicin—pancreatic cancer	3.97e-05	0.00015	CcSEcCtD
Ofloxacin—Pain—Doxorubicin—pancreatic cancer	3.95e-05	0.00015	CcSEcCtD
Ofloxacin—Constipation—Doxorubicin—pancreatic cancer	3.95e-05	0.00015	CcSEcCtD
Ofloxacin—Body temperature increased—Epirubicin—pancreatic cancer	3.95e-05	0.000149	CcSEcCtD
Ofloxacin—Abdominal pain—Epirubicin—pancreatic cancer	3.95e-05	0.000149	CcSEcCtD
Ofloxacin—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—pancreatic cancer	3.92e-05	0.0201	CbGpPWpGaD
Ofloxacin—Feeling abnormal—Doxorubicin—pancreatic cancer	3.81e-05	0.000144	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	3.78e-05	0.000143	CcSEcCtD
Ofloxacin—ABCC1—S1P1 pathway—KDR—pancreatic cancer	3.76e-05	0.0192	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TFF1—pancreatic cancer	3.75e-05	0.0191	CbGpPWpGaD
Ofloxacin—Hypersensitivity—Epirubicin—pancreatic cancer	3.68e-05	0.000139	CcSEcCtD
Ofloxacin—Urticaria—Doxorubicin—pancreatic cancer	3.67e-05	0.000139	CcSEcCtD
Ofloxacin—Body temperature increased—Doxorubicin—pancreatic cancer	3.66e-05	0.000138	CcSEcCtD
Ofloxacin—Abdominal pain—Doxorubicin—pancreatic cancer	3.66e-05	0.000138	CcSEcCtD
Ofloxacin—TOP2A—Gastric Cancer Network 1—NOTCH1—pancreatic cancer	3.64e-05	0.0186	CbGpPWpGaD
Ofloxacin—Asthenia—Epirubicin—pancreatic cancer	3.59e-05	0.000136	CcSEcCtD
Ofloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	3.55e-05	0.0181	CbGpPWpGaD
Ofloxacin—Pruritus—Epirubicin—pancreatic cancer	3.54e-05	0.000134	CcSEcCtD
Ofloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—BRCA2—pancreatic cancer	3.47e-05	0.0177	CbGpPWpGaD
Ofloxacin—Diarrhoea—Epirubicin—pancreatic cancer	3.42e-05	0.000129	CcSEcCtD
Ofloxacin—Hypersensitivity—Doxorubicin—pancreatic cancer	3.41e-05	0.000129	CcSEcCtD
Ofloxacin—Asthenia—Doxorubicin—pancreatic cancer	3.32e-05	0.000125	CcSEcCtD
Ofloxacin—Dizziness—Epirubicin—pancreatic cancer	3.3e-05	0.000125	CcSEcCtD
Ofloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—HES1—pancreatic cancer	3.28e-05	0.0168	CbGpPWpGaD
Ofloxacin—Pruritus—Doxorubicin—pancreatic cancer	3.27e-05	0.000124	CcSEcCtD
Ofloxacin—Vomiting—Epirubicin—pancreatic cancer	3.18e-05	0.00012	CcSEcCtD
Ofloxacin—Diarrhoea—Doxorubicin—pancreatic cancer	3.16e-05	0.00012	CcSEcCtD
Ofloxacin—Rash—Epirubicin—pancreatic cancer	3.15e-05	0.000119	CcSEcCtD
Ofloxacin—Dermatitis—Epirubicin—pancreatic cancer	3.15e-05	0.000119	CcSEcCtD
Ofloxacin—Headache—Epirubicin—pancreatic cancer	3.13e-05	0.000118	CcSEcCtD
Ofloxacin—Dizziness—Doxorubicin—pancreatic cancer	3.06e-05	0.000116	CcSEcCtD
Ofloxacin—Nausea—Epirubicin—pancreatic cancer	2.97e-05	0.000112	CcSEcCtD
Ofloxacin—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—pancreatic cancer	2.95e-05	0.0151	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	2.94e-05	0.015	CbGpPWpGaD
Ofloxacin—Vomiting—Doxorubicin—pancreatic cancer	2.94e-05	0.000111	CcSEcCtD
Ofloxacin—Rash—Doxorubicin—pancreatic cancer	2.92e-05	0.00011	CcSEcCtD
Ofloxacin—Dermatitis—Doxorubicin—pancreatic cancer	2.91e-05	0.00011	CcSEcCtD
Ofloxacin—Headache—Doxorubicin—pancreatic cancer	2.9e-05	0.00011	CcSEcCtD
Ofloxacin—Nausea—Doxorubicin—pancreatic cancer	2.75e-05	0.000104	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—DAXX—pancreatic cancer	2.72e-05	0.0139	CbGpPWpGaD
Ofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	2.68e-05	0.0137	CbGpPWpGaD
Ofloxacin—ABCC1—S1P1 pathway—PTGS2—pancreatic cancer	2.63e-05	0.0134	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—SYCP1—pancreatic cancer	2.52e-05	0.0129	CbGpPWpGaD
Ofloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—NOTCH1—pancreatic cancer	2.48e-05	0.0127	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	2.4e-05	0.0123	CbGpPWpGaD
Ofloxacin—TOP2A—Gastric Cancer Network 2—CTNNB1—pancreatic cancer	2.3e-05	0.0117	CbGpPWpGaD
Ofloxacin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—pancreatic cancer	2.23e-05	0.0114	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	2.21e-05	0.0113	CbGpPWpGaD
Ofloxacin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	2.12e-05	0.0108	CbGpPWpGaD
Ofloxacin—ABCC1—S1P1 pathway—VEGFA—pancreatic cancer	2.07e-05	0.0106	CbGpPWpGaD
Ofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TYMS—pancreatic cancer	2.02e-05	0.0103	CbGpPWpGaD
Ofloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—pancreatic cancer	1.97e-05	0.0101	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	1.92e-05	0.0098	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—AHR—pancreatic cancer	1.89e-05	0.00966	CbGpPWpGaD
Ofloxacin—TOP2A—Gastric Cancer Network 2—MYC—pancreatic cancer	1.86e-05	0.0095	CbGpPWpGaD
Ofloxacin—TOP2A—Gastric Cancer Network 2—EGFR—pancreatic cancer	1.82e-05	0.0093	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	1.8e-05	0.00921	CbGpPWpGaD
Ofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	1.78e-05	0.00911	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	1.72e-05	0.00879	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	1.7e-05	0.00868	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	1.67e-05	0.00853	CbGpPWpGaD
Ofloxacin—ABCC2—NRF2 pathway—NFE2L2—pancreatic cancer	1.66e-05	0.00851	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	1.62e-05	0.00826	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—AHR—pancreatic cancer	1.62e-05	0.00826	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—AHR—pancreatic cancer	1.62e-05	0.00826	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	1.6e-05	0.00817	CbGpPWpGaD
Ofloxacin—ABCC2—NRF2 pathway—TGFA—pancreatic cancer	1.59e-05	0.00812	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NFE2L2—pancreatic cancer	1.57e-05	0.00805	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—NFE2L2—pancreatic cancer	1.57e-05	0.00805	CbGpPWpGaD
Ofloxacin—ABCC2—NRF2 pathway—SLC2A2—pancreatic cancer	1.55e-05	0.00794	CbGpPWpGaD
Ofloxacin—TOP2A—Gastric Cancer Network 2—TP53—pancreatic cancer	1.53e-05	0.0078	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	1.48e-05	0.00759	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	1.46e-05	0.00746	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—EZH2—pancreatic cancer	1.43e-05	0.00728	CbGpPWpGaD
Ofloxacin—TOP2A—Mitotic G1-G1/S phases—TYMS—pancreatic cancer	1.42e-05	0.00725	CbGpPWpGaD
Ofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RB1—pancreatic cancer	1.37e-05	0.00699	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	1.36e-05	0.00695	CbGpPWpGaD
Ofloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	1.34e-05	0.00685	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	1.32e-05	0.00673	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	1.3e-05	0.00666	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—RBBP8—pancreatic cancer	1.29e-05	0.00658	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	1.25e-05	0.00639	CbGpPWpGaD
Ofloxacin—ABCC1—Arachidonic acid metabolism—PTGS2—pancreatic cancer	1.21e-05	0.00619	CbGpPWpGaD
Ofloxacin—ABCC2—NRF2 pathway—HSPA1A—pancreatic cancer	1.19e-05	0.00611	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	1.13e-05	0.00578	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—PPP2R5B—pancreatic cancer	1.12e-05	0.00573	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	1.09e-05	0.00559	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	1.07e-05	0.00549	CbGpPWpGaD
Ofloxacin—CYP1A2—Estrogen Receptor Pathway—STAT3—pancreatic cancer	1.05e-05	0.00539	CbGpPWpGaD
Ofloxacin—CYP1A2—Melatonin metabolism and effects—APOE—pancreatic cancer	1.04e-05	0.00531	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—TYMS—pancreatic cancer	1.03e-05	0.00527	CbGpPWpGaD
Ofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—pancreatic cancer	1.02e-05	0.00519	CbGpPWpGaD
Ofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	1.01e-05	0.00517	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—PPP2R5B—pancreatic cancer	1e-05	0.00512	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—FOXM1—pancreatic cancer	9.98e-06	0.0051	CbGpPWpGaD
Ofloxacin—TOP2A—Mitotic G1-G1/S phases—RB1—pancreatic cancer	9.62e-06	0.00492	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	9.06e-06	0.00463	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—FOXM1—pancreatic cancer	8.93e-06	0.00456	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—pancreatic cancer	8.77e-06	0.00448	CbGpPWpGaD
Ofloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—pancreatic cancer	8.46e-06	0.00432	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	8.15e-06	0.00416	CbGpPWpGaD
Ofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—pancreatic cancer	8.14e-06	0.00416	CbGpPWpGaD
Ofloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	7.96e-06	0.00407	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	7.8e-06	0.00399	CbGpPWpGaD
Ofloxacin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—pancreatic cancer	7.78e-06	0.00398	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—PPARG—pancreatic cancer	7.31e-06	0.00374	CbGpPWpGaD
Ofloxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—pancreatic cancer	7.14e-06	0.00365	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	6.81e-06	0.00348	CbGpPWpGaD
Ofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—pancreatic cancer	6.69e-06	0.00342	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	5.99e-06	0.00306	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RB1—pancreatic cancer	5.98e-06	0.00306	CbGpPWpGaD
Ofloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—pancreatic cancer	5.73e-06	0.00293	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	5.56e-06	0.00284	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	5.41e-06	0.00277	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	5.36e-06	0.00274	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	5.22e-06	0.00267	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—TYMS—pancreatic cancer	5.2e-06	0.00266	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	5.14e-06	0.00263	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—PTEN—pancreatic cancer	5.01e-06	0.00256	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	4.98e-06	0.00254	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	4.92e-06	0.00251	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—pancreatic cancer	4.92e-06	0.00251	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—BRCA2—pancreatic cancer	4.89e-06	0.0025	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	4.84e-06	0.00248	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PRSS1—pancreatic cancer	4.82e-06	0.00247	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—ZNRF3—pancreatic cancer	4.82e-06	0.00247	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	4.72e-06	0.00241	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—TYMS—pancreatic cancer	4.65e-06	0.00238	CbGpPWpGaD
Ofloxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—pancreatic cancer	4.6e-06	0.00235	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—DTX1—pancreatic cancer	4.36e-06	0.00223	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	4.34e-06	0.00222	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	4.33e-06	0.00221	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	4.25e-06	0.00217	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—TERT—pancreatic cancer	4.05e-06	0.00207	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	4.04e-06	0.00207	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PRSS1—pancreatic cancer	4.04e-06	0.00207	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	4.01e-06	0.00205	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—SRC—pancreatic cancer	3.98e-06	0.00203	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—pancreatic cancer	3.98e-06	0.00203	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—pancreatic cancer	3.87e-06	0.00198	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—pancreatic cancer	3.83e-06	0.00196	CbGpPWpGaD
Ofloxacin—ABCC2—NRF2 pathway—TGFB1—pancreatic cancer	3.76e-06	0.00192	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	3.69e-06	0.00188	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—DTX4—pancreatic cancer	3.66e-06	0.00187	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	3.56e-06	0.00182	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—pancreatic cancer	3.56e-06	0.00182	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PPP2R5B—pancreatic cancer	3.56e-06	0.00182	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—pancreatic cancer	3.56e-06	0.00182	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—RB1—pancreatic cancer	3.53e-06	0.0018	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ARG2—pancreatic cancer	3.5e-06	0.00179	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—pancreatic cancer	3.49e-06	0.00178	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—pancreatic cancer	3.49e-06	0.00178	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—HEY2—pancreatic cancer	3.42e-06	0.00175	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—TP53—pancreatic cancer	3.42e-06	0.00175	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—pancreatic cancer	3.32e-06	0.0017	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—pancreatic cancer	3.32e-06	0.0017	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—pancreatic cancer	3.29e-06	0.00168	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—HEY1—pancreatic cancer	3.17e-06	0.00162	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—RB1—pancreatic cancer	3.15e-06	0.00161	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—pancreatic cancer	3.1e-06	0.00159	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—TYMP—pancreatic cancer	3.06e-06	0.00157	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	3.01e-06	0.00154	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—JAG2—pancreatic cancer	2.81e-06	0.00144	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—pancreatic cancer	2.8e-06	0.00143	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—CDKN2A—pancreatic cancer	2.77e-06	0.00142	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—MEN1—pancreatic cancer	2.77e-06	0.00142	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—SLC2A2—pancreatic cancer	2.75e-06	0.00141	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—SHH—pancreatic cancer	2.64e-06	0.00135	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—pancreatic cancer	2.62e-06	0.00134	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—IAPP—pancreatic cancer	2.61e-06	0.00133	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.53e-06	0.00129	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—HSPA1B—pancreatic cancer	2.51e-06	0.00128	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GLP1R—pancreatic cancer	2.47e-06	0.00126	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—DPYD—pancreatic cancer	2.43e-06	0.00124	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—CCND1—pancreatic cancer	2.34e-06	0.0012	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—SLC2A2—pancreatic cancer	2.3e-06	0.00118	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.28e-06	0.00117	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—JAG1—pancreatic cancer	2.24e-06	0.00115	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.2e-06	0.00112	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CD44—pancreatic cancer	2.13e-06	0.00109	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—HSPA1A—pancreatic cancer	2.11e-06	0.00108	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—MYC—pancreatic cancer	2.1e-06	0.00107	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2e-06	0.00102	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—MYC—pancreatic cancer	1.88e-06	0.000961	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CD44—pancreatic cancer	1.78e-06	0.000912	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.75e-06	0.000893	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.73e-06	0.000885	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GCG—pancreatic cancer	1.71e-06	0.000874	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—SMAD4—pancreatic cancer	1.68e-06	0.00086	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—HES1—pancreatic cancer	1.64e-06	0.00084	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—STK11—pancreatic cancer	1.61e-06	0.000822	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—TP53—pancreatic cancer	1.54e-06	0.000789	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PRSS1—pancreatic cancer	1.53e-06	0.000784	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.51e-06	0.000772	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—TERT—pancreatic cancer	1.44e-06	0.000736	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—TYMS—pancreatic cancer	1.38e-06	0.000707	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—HIF1A—pancreatic cancer	1.38e-06	0.000704	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—TSC2—pancreatic cancer	1.37e-06	0.000702	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—APOE—pancreatic cancer	1.34e-06	0.000687	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ARG2—pancreatic cancer	1.33e-06	0.00068	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—NOTCH1—pancreatic cancer	1.24e-06	0.000634	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—EGF—pancreatic cancer	1.2e-06	0.000613	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—TYMP—pancreatic cancer	1.16e-06	0.000594	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—APOE—pancreatic cancer	1.13e-06	0.000575	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PIK3CD—pancreatic cancer	1.07e-06	0.000545	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.07e-06	0.000544	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PIK3CG—pancreatic cancer	1.02e-06	0.000519	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PPARG—pancreatic cancer	9.8e-07	0.000501	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	9.6e-07	0.00049	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GLP1R—pancreatic cancer	9.37e-07	0.000479	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PIK3CB—pancreatic cancer	9.29e-07	0.000475	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—DPYD—pancreatic cancer	9.22e-07	0.000471	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PTGS2—pancreatic cancer	9.21e-07	0.000471	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PIK3CD—pancreatic cancer	8.93e-07	0.000456	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	8.75e-07	0.000447	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	8.66e-07	0.000443	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	8.36e-07	0.000427	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CTNNB1—pancreatic cancer	8.24e-07	0.000421	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PTEN—pancreatic cancer	8.03e-07	0.00041	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PIK3CB—pancreatic cancer	7.78e-07	0.000398	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PTGS2—pancreatic cancer	7.71e-07	0.000394	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	7.61e-07	0.000389	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—SRC—pancreatic cancer	7.45e-07	0.000381	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—STAT3—pancreatic cancer	7.18e-07	0.000367	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—NRAS—pancreatic cancer	7.16e-07	0.000366	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CD44—pancreatic cancer	6.78e-07	0.000346	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PTEN—pancreatic cancer	6.72e-07	0.000344	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—MYC—pancreatic cancer	6.67e-07	0.000341	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—TGFB1—pancreatic cancer	6.66e-07	0.00034	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	6.64e-07	0.000339	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	6.57e-07	0.000336	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—EGFR—pancreatic cancer	6.53e-07	0.000334	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GCG—pancreatic cancer	6.5e-07	0.000332	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—KRAS—pancreatic cancer	6.16e-07	0.000315	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—STK11—pancreatic cancer	6.11e-07	0.000312	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	5.73e-07	0.000293	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PIK3CA—pancreatic cancer	5.66e-07	0.00029	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—TYMS—pancreatic cancer	5.25e-07	0.000269	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—HRAS—pancreatic cancer	5.24e-07	0.000268	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PIK3CA—pancreatic cancer	4.74e-07	0.000242	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—AKT1—pancreatic cancer	4.63e-07	0.000237	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—APOE—pancreatic cancer	4.27e-07	0.000218	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.04e-07	0.000207	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—AKT1—pancreatic cancer	3.87e-07	0.000198	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	3.86e-07	0.000197	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PPARG—pancreatic cancer	3.72e-07	0.00019	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	3.39e-07	0.000173	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	2.96e-07	0.000151	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PTGS2—pancreatic cancer	2.93e-07	0.00015	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PTEN—pancreatic cancer	2.55e-07	0.000131	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	1.8e-07	9.21e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—AKT1—pancreatic cancer	1.47e-07	7.52e-05	CbGpPWpGaD
